NEW YORK (GenomeWeb News) — TriPath Imaging today said that its shareholders have approved Becton Dickinson’s $350-million bid to acquire the company.
 
The company said it expects the deal to close by tomorrow.
 
In September, BD said it would acquire 93.5 percent of TriPath’s shares for $350 million. TriPath said today that BD has agreed to pay $9.25 a share for the firm’s common stock, which is where the stock was trading this afternoon.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.